Title: One-pot high-yielding synthesis of the DPP4-selective inhibitor ABT-341 by a four-component coupling mediated by a diphenylprolinol silyl ether Ishikawa H, Honma M, Hayashi Y Ref: Angew Chem Int Ed Engl, 50:2824, 2011 : PubMed
Title: Characterization of inhibitory effect of carbapenem antibiotics on the deconjugation of valproic acid glucuronide Masuo Y, Ito K, Yamamoto T, Hisaka A, Honma M, Suzuki H Ref: Drug Metabolism & Disposition: The Biological Fate of Chemicals, 38:1828, 2010 : PubMed
Serum concentrations of valproic acid (VPA) are markedly decreased by coadministration of carbapenem antibiotics (CBPMs). Although inhibition of deconjugation of VPA-glucuronide (VPA-G) to VPA by CBPMs has been proposed as one of the mechanisms to account for this drug-drug interaction, little information is available on the mode of inhibition. In the present study, we characterized the enzyme involved in the deconjugation of VPA-G by using human and rat liver cytosol. It is suggested that 1) deconjugation activity inhibited by CBPMs may be selective for VPA-G, 2) deconjugation of VPA-G may be mediated by enzyme(s) other than beta-glucuronidase, and 3) the irreversible inactivation may be responsible for the inhibition of deconjugation of VPA-G by CBPMs. Finally, the kinetic parameters for inactivation (K'(app) and k(inact)) were determined for four CBPMs of diverse structure from in vitro experiments. Based on the results of simulation analyses with these parameters and the degradation rate constant of the putative VPA-G deconjugation enzyme obtained from experiments using rats, it is probable that the deconjugation enzyme for VPA-G in the liver is rapidly and mostly inactivated by these CBPMs under clinical situations.
Title: Effects of papaverine and its interaction with isoprenaline and carbachol on the contractile force and cyclic nucleotide levels of the canine ventricular myocardium Endoh M, Honma M Ref: Naunyn Schmiedebergs Arch Pharmacol, 306:241, 1979 : PubMed
